Studies: Drugmakers are gaming the patent system with misrepresentations, ancillary patents

Regulatory News

Regulatory NewsMichele G. Sullivan

Advertising, Promotion and LabelingBiologics/ biosimilars/ vaccinesBiotechnologyCompliancePharmaceuticalsRegulatory Intelligence/PolicyUnited States